Clinical Trials for Cogent Biosciences

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cogent Biosciences

Clinical Trials (5)

NCT06777316
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
PHASE1/PHASE2Recruiting
110 participants
Started: Jan 22, 2025 · Completed: Jun 30, 2027
12 conditions1 sponsor15 locations
NCT06208748
SARC044: a Phase II Trial of Bezuclastinib in Combination with Sunitinib in Patients with GIST
PHASE2Recruiting
40 participants
Started: Aug 1, 2024 · Completed: Jun 30, 2027
2 conditions4 sponsors4 locations
NCT05186753
(Summit) a Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients with Indolent or Smoldering Systemic Mastocytosis
PHASE2Active, not recruiting
207 participants
Started: Jun 27, 2022 · Completed: Apr 30, 2030
8 conditions1 sponsor69 locations
NCT05208047
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
PHASE3Active, not recruiting
442 participants
Started: Apr 14, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor126 locations
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
PHASE2Recruiting
140 participants
Started: Nov 9, 2021 · Completed: Jul 31, 2026
4 conditions1 sponsor42 locations